Wunderman wins AstraZeneca's Faslodex

Share this article:

Pharmaceuticals marketer AstraZeneca has tapped Wunderman New York to launch a consumer campaign for Faslodex, a later-stage breast cancer prescription drug for women.

The direct marketing agency competed with CommonHealth and Digitas' Medical Broadcasting Company agency for the account. Billings were not disclosed.

"This helps us broaden our portfolio with their oncology division," said Steve Zammarchi, president/CEO of Wunderman New York. "We have to create awareness for the product in the direct-to-consumer marketplace."

Wunderman New York currently handles the Arimidex and Casodex/Zoladex brands, which are part of AstraZeneca's oncology medications.

A print campaign for Faslodex will begin this summer. Call to action and theme have not yet been disclosed.

Share this article:

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

John Wanamaker Is Dead, Long Live the CMO

John Wanamaker Is Dead, Long Live the CMO

A century-old motto isn't—and shouldn't be—relevant today. CMOs need to get with the times and put their customer knowledge to good use.

Unleashing the True Power of the Customer

Unleashing the True Power of the Customer

Retailers who harness customer loyalty program data can create a customer-centric competitive advantage.

News Byte: Gartner Retail Expert Joins eCommera as CMO

News Byte: Gartner Retail Expert Joins eCommera as ...

Kevin Sterneckert brings a wealth of knowledge and experience to eCommera.